Global Talent for commercial R&D teams: what the UKRI host expansion actually permits

UKRI's approved research organisation list was updated on 31 July 2026. The government then announced on 6 August that more than 100 additional businesses could access the Global Talent route, including research-intensive companies across life sciences, advanced manufacturing, digital technologies, clean energy and the creative industries.

The mechanism is the existing UKRI Endorsed Funder fast track. Appendix Global Talent continues to govern immigration permission, while UKRI's published eligibility and organisation lists determine whether the endorsement gateway is available. The announcement does not create a separate company-sponsored Global Talent visa.

That classification matters. Businesses should use the expanded list immediately where the complete criteria are met, but should not read the press announcement as displacing the current Rules or official endorsement guidance.

The employing or hosting organisation must be approved by UKRI and based in the United Kingdom. The published list now includes multinational employers, specialist technology companies, research institutes, charities and public bodies. It should be checked at the date the endorsement case is prepared.

A brand, group relationship or similarity of name should not be treated as sufficient. The employing or hosting entity identified in the application and institutional letter should be reconciled with the organisation UKRI has approved, particularly where a group contains several UK companies or research operations.

An organisation not on the list cannot solve that problem by describing itself as research intensive. UKRI provides a process through which research-intensive organisations can register interest, but possible future approval is not present eligibility for an individual application.

The individual must either lead a unique research or innovation project or contribute to research that develops new technology or methodology. A principal or co-investigator leading research must have a PhD or equivalent research experience, including clinical or industrial research, and must have participated actively in the relevant field.

A person making a critical contribution requires relevant research experience and a UK bachelor's degree, an equivalent overseas research degree or equivalent research experience. The official framework can therefore accommodate researchers and technical specialists who are essential to the funded work, but it does not extend to every product, engineering or operational role within an approved company.

The correct question is what the individual will do within the funded research, why that work is critical and how their experience equips them to do it. Prestige, remuneration and organisational importance are relevant context; none substitutes for the pathway's function-specific requirements.

At least 1 year must remain on the employment contract or hosting agreement, and the individual must spend at least half of their working time on the qualifying grant. Principal and co-investigators may rely on more than one grant where the combined work meets the 50% requirement.

Those conditions should be tested against the real allocation of duties, not inserted into a letter after the role has been designed. The job description, project plan, grant record, reporting line and working-time allocation should describe the same position.

A mixed commercial role may still qualify where the funded research occupies the required proportion and the remaining criteria are met. If research is secondary to product management, general leadership, business development or service delivery, the Endorsed Funder pathway may not fit even though the employer is an approved R&D business.

The application requires a letter from the director of human resources or equivalent at the approved organisation. It must confirm the position and department, acceptance of the employment or hosting arrangement, that the individual is essential to the grant, and that at least half of their agreed working time will be spent on it.

Where the individual was not specifically named on the grant application, the letter must also address the fair recruitment process. That is not an invitation to provide a generic assurance. The organisation should be able to preserve the recruitment chronology, selection basis and connection between the selected person and the funded work.

The institutional letter should be the conclusion of an internal verification exercise involving the grant owner, research lead, HR and, where appropriate, immigration counsel. It should not be the first point at which those stakeholders compare their understanding of the role.

The UKRI pathway does not require the company to sponsor the individual under the worker sponsorship system. Once Global Talent permission is granted, the person can generally work, change employment and undertake self-employment within the conditions of the route, and a UKRI-endorsed principal applicant can potentially qualify for settlement after 3 years.

That flexibility can be attractive to the researcher and can reduce the business's dependence on a sponsor licence for the particular hire. It also means Global Talent should not be treated as a substitute Certificate of Sponsorship. The company supports the endorsement evidence, but does not acquire the same immigration control over the individual's continuing employment.

Skilled Worker may remain the better route where the grant criteria are not met, the role is not sufficiently connected to funded research or the business requires a conventional sponsored-employment structure. The comparison should include eligibility, evidence, timing, cost, worker flexibility, dependants and settlement rather than assuming the route with the lighter employer burden is automatically preferable.

The new host status is most valuable when the organisation can identify eligible grants and roles early. A central record of endorsed funders, award databases, grant duration and value, named researchers, time allocation and contract dates allows recruitment teams to test the pathway before making promises to a candidate.

Responsibility should also be clear. The research lead can establish scientific contribution; finance or grants teams can verify the award; HR can confirm the employment and recruitment record; immigration advisers can test route fit and evidence. No single stakeholder is likely to hold the complete answer without that coordination.

The operating model should include an alternative-route decision. If a proposed hire falls outside the UKRI criteria, the business should know whether Skilled Worker, an academic appointment, individual fellowship, peer review or another route can meet the underlying objective without distorting the research role.